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Correlation Analysis of Production and Photoisomerization of
Epidermal Urocanic Acid Versus Induction and Repair of
DNA Photoproducts in the Human Skin In Situ
To the Editor:
Photocarcinogenesis is a complex process comprising the induction
of mutations in cellular DNA by exposure of the skin to ultraviolet
(UV) radiation, the failure of the nucleotide excision repair system
to completely restore the integrity of the genome, and the
concurrent modulation of the cutaneous immune system. The two
important chromophores for UV radiation in the epidermis are
urocanic acid (UCA) and DNA, both considered to be involved in
photocarcinogenesis. Downregulation of the immune system by
DNA damage (Vink et al, 1997) or cis-urocanic acid (cis-UCA)
(Noonan and De Fabo, 1992), the immediate photoisomerization
product of the endogenous trans-UCA, may contribute to the
growth of highly antigenic, UV-induced skin cancers. The
formation and repair of DNA photoproducts as well as the
cutaneous concentration levels of UCA share one interesting
feature in common; they show signi®cant interindividual variation
(Snellman et al, 1997; Bykov et al, 1998). High formation rates or
defective repair of DNA photoproducts in the skin of an individual
with high (cis-)UCA levels would pose an increased risk of UV
tumors. Data on such a possibility are not currently available. We
have compared the induction and repair of DNA photoproducts
and UCA production in the Caucasian skin.
The study was compiled from available data of a total of 17
volunteering subjects (eight females and nine males) who had
earlier been assessed both for photoisomerization of UCA
(Snellman et al, 1999) and for the formation of DNA photoproducts
in situ (Xu et al, 2000a,b,c). Eight of the subjects were previously
treated for cutaneous malignant melanoma (CMM), four for basal
cell carcinoma (BCC), and ®ve were healthy controls (Table I).
UV irradiation was performed with a spectroradiometrically
calibrated solar-simulating UV lamp Philips HP411/A speci®ed
recently (Snellman et al, 1997, 1999; Xu et al, 2000a,b,c). UCA was
sampled both from the protected and UV-exposed [only 10 J per
m2CIE2 (Commission Internationale de l'EÂclairage; McKinlay and
Diffey, 1987) erythemally weighted irradiation dose to avoid the
photostationary state be reached] back skin using the Finn
Chamberâ epidermal sampling (Jansen et al, 1991). The formation
of cyclobutane pyrimidine dimers (CPD) and 6±4 photoproducts in
situ were assessed after an erythemally weighted dose of 400 J per
m2CIE2. This was the highest minimal erythema dose detected in
our probands and high enough for the follow-up of repair rates of
UV photoproducts. Skin biopsies were taken immediately and 24 h
after the exposure and analyzed with the 32P-postlabeling technique
(Bykov and Hemminki, 1995; Bykov et al, 1999).
The levels of photoproducts measured immediately after irradi-
ation showed wide interindividual differences, as did the UCA
levels (Table I). CPD and 6±4 photoproducts were formed with
different ef®cacy, the 6±4 photoproduct levels (TT-T and TT-C)
being 15%±17% of those of CPD, conforming with results of a
larger series (Xu et al, 2000c). A new ®nding, which needs to be
con®rmed in future studies, was that the total UCA concentration
rose in 16 of 17 subjects after UV exposure. This phenomenon may
be a result of a rapid induction of the histidase enzyme either by the
alkaline sampling conditions (Jansen et al, 1991) or by the used
irradiation type and dose, a combination of the two, or it may
re¯ect an acute irradiation-induced change in the epidermal
environment to allow increased diffusion of UCA into the
sampling chambers. We calculated the Pearson's correlation
coef®cients for epidermal total UCA or cis-UCA levels and DNA
photoproducts. Con®dence intervals for correlation were deter-
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Table I. Volunteers and measured photoproduct levels (per megabase of DNA) and epidermal total (nmol per cm2) and
proportional (%) cis-UCA concentrations
Subject/
gender/
statusa
Age
(y)
TT-T TT-C TT=T TT=C Total UCA % cis-UCA
Immediately
post-UVb
24 h
post-UV
Immediately
post-UV
24 h
post-UV
Immediately
post-UV
24 h
post-UV
Immediately
post-UV
24 h
post-UV Baseline
Immediately
post-UVc Baseline
Immediately
post-UVc
1/F/CMM 32 0.9 0.0 0.3 0.0 6.9 2.5 10.1 2.8 14.8 16.3 2.5 4.7
2/M/CMM 48 0.8 0.1 1.9 0.2 5.1 2.2 5.4 0.9 14.7 13.0 5.7 11.7
3/M/CMM 58 0.1 0.2 0.2 0.1 1.8 2.5 1.5 1.0 9.3 17.8 5.6 9.6
4/M/CMM 62 0.7 1.2 0.8 0.8 9.8 10.4 8.2 7.9 16.4 20.3 3.4 6.7
5/F/CMM 56 0.7 0.5 0.4 0.2 10.3 9.5 8.3 8.5 15.9 28.7 3.2 6.8
6/F/CMM 31 0.8 N/Ad 0.9 N/A 12.1 N/A 7.3 N/A 13.6 18.1 3.1 6.3
7/M/CMM 75 0.9 0.0 1.3 0.6 9.8 8.0 13.5 4.8 8.2 12.5 5.6 9.6
8/M/CMM 48 0.7 0.2 0.7 0.4 11.2 7.4 5.5 2.7 3.7 14.5 6.0 8.0
9/F/BCC 50 1.1 0.9 2.0 1.6 8.6 2.3 5.8 0.0 14.2 18.1 2.3 5.1
10/M/BCC 67 0.8 N/A 5.4 N/A 13.3 N/A N/A N/A 12.8 16.0 4.8 6.0
11/F/BCC 67 3.2 0.2 0.6 0.3 6.7 5.7 11.3 10.7 21.4 31.2 1.3 7.0
12/M/BCC 72 1.2 0.2 3.2 1.1 10.7 8.0 26.6 9.8 16.4 28.4 3.4 6.4
13/M/CO 47 1.2 0.2 1.0 0.2 8.0 6.3 7.4 4.3 5.2 8.7 4.0 10.3
14/F/CO 35 0.1 0.1 0.2 0.2 1.6 0.9 1.32 0.4 6.0 13.7 3.5 8.8
15/M/CO 50 0.4 0.3 0.7 0.3 12.6 6.1 10.0 2.3 24.4 27.7 1.2 4.5
16/F/CO 49 6.3 2.6 1.5 0.5 5.8 4.4 5.5 2.7 20.9 36.1 4.8 6.9
17/F/CO 49 2.1 1.7 3.7 1.4 8.1 3.4 8.6 1.2 32.3 34.5 3.7 8.1
aCMM, cutaneous malignant melanoma; BCC, basal cell carcinoma; CO, healthy control subject.
bErythemally weighted UV dose of 400 J per m2CIE2 was used for induction of all DNA photoproduct types.
c10 J per m2CIE2 erythemally weighted UV dose.
dN/A, not applicable.
Table II. Correlation analysis of DNA photoproducts and epidermal UCA concentration in the human skin in situ (n = 17
subjects unless speci®ed)
Photoproduct
vs. UCA
parametera
Immediate DNA photoproducts
(post-UV, 400 J/m2CIE)
b vs.
Remaining DNA photoproducts at 24 h
(post-UV, 400 J/m2CIE)
bf vs.
Repaired DNA photoproducts
(immediate ± remaining)f vs.
UCA
(baseline,
no (UV)
UCA
(post-UV,
10 J/m2CIE)
b
UCA
(post-UV
-baseline)
UCA
(baseline,
no (UV)
UCA
(post-UV,
10 J/m2CIE)
b
UCA
(post-UV
± baseline)
UCA
(baseline,
no (UV)
UCA
(post-UV,
10 J/m2CIE)
b
UCA
(post-UV
± baseline)
TT-T vs.
Total UCA
0.44c
(±0.06 0.76)d
p = 0.079
0.63
(0.22 0.85)
p = 0.0063*
0.46
(±0.03 0.77)
p = 0.063
0.55
(0.06 0.83)
p = 0.032*
0.64
(0.18 0.87)
p = 0.011*
0.27
(±0.28 0.69)
p = 0.33
0.24
(±0.31 0.67)
p = 0.40
0.45
(±0.08 0.78)
p = 0.090
0.45
(±0.09 0.78)
p = 0.096
TT-T vs.
cis-UCA
0.48
(±0.01 0.78)
p = 0.053
0.62
(0.19 0.85)
p = 0.0085*
0.52
(0.05 0.80)
p = 0.034*
0.70
(0.29 0.89)
p = 0.0038*
0.61
(0.14 0.86)
p = 0.016*
0.37
(±0.18 0.74)
p = 0.18
0.22
(±0.33 0.66)
p = 0.44
0.45
(±0.08 0.78)
p = 0.095
0.48
(±0.05 0.79)
p = 0.072
TT-C vs.
Total UCA
0.31
(±0.20 0.69)
(±0.62 0.38)
p = 0.23
0.16
(±0.35 0.59)
p = 0.55
±0.21
(±0.62 0.31)
p = 0.43
0.40
(±0.15 0.75)
p = 0.15
0.32
(±0.24 0.72)
p = 0.25
±0.05
(±0.55 0.47)
p = 0.85
0.46
(±0.06 0.79)
p = 0.081
0.32
(±0.23 0.72)
p = 0.24
±0.16
p = 0.57
TT-C vs.
cis-UCA
0.53
(0.06 0.80)
p = 0.029
0.15
(±0.36 0.59)
p = 0.57
±0.14
(±0.58 0.36)
p = 0.59
0.35
(±0.19 0.73)
p = 0.20
0.24
(±0.31 0.67)
p = 0.39
0.09
(±0.44 0.58)
p = 0.75
0.70
(0.29 0.89)
p = 0.0038*
0.49
(±0.03 0.80)
p = 0.063
0.20
(±0.35 0.65)
p = 0.47
TT = T vs.
Total UCA
0.15
(±0.35 0.59)
p = 0.56
0.09
(±0.41 0.55)
p = 0.73
±0.08
(±0.54 0.42)
p = 0.76
±0.02
(±0.53 0.50)
p = 0.95
0.16
(±0.39 0.62)
p = 0.57
0.32
(±0.23 0.71)
p = 0.25
0.33
(±0.22 0.72)
p = 0.22
0.08
(±0.45 0.57)
p = 0.77
±0.39
(±0.75 0.15)
p = 0.15
TT = T vs.
% cis-UCA
±0.19
(±0.61 0.32)
p = 0.47
±0.52
(±0.80 ±0.05)
p = 0.033*
±0.52
(±0.80 ±0.05)
p = 0.033*
±0.02
(±0.52 0.50)
p = 0.96
±0.16
(±0.62 0.39)
p = 0.58
±0.21
(±0.65 0.34)
p = 0.45
±0.35
(±0.73 0.20)
p = 0.20
±0.47
(±0.79 0.06)
p = 0.078
±0.31
(±0.71 0.24)
p = 0.26
TT = C vs.
Total UCA
0.25
(±0.29 0.66)e
p = 0.36
0.30
(±0.23 0.69)e
p = 0.26
0.150
(±0.37 0.60)
p = 0.58
0.13
(±0.41 0.60)
p = 0.66
0.34
(±0.21 0.73)
p = 0.22
0.418
(±0.12 0.77)
p = 0.12
0.22
(±0.33 0.66)
p = 0.43
0.12
(±0.42 0.60)
p = 0.67
±0.14
(±0.61 0.40)
p = 0.63
aDNA photoproduct and UCA parameters subjected to correlation analysis.
bErythemally weighted UV doses.
cPearson's correlation coef®cients.
dThe 95% con®dence intervals of correlation after Fisher's Z transformation.
en = 16 subjects.
fn = 15 subjects.
*Statistically signi®cant correlation.
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mined after Fisher's Z transformation using GraphPad InStat
program (GraphPad Software, San Diego, CA). Selected correl-
ation pairs are shown in Table II and include all signi®cant
correlation results. The majority of the found correlates were
associated with 6±4 photoproducts of the TT-T type (Table II).
The data would suggest that the skin of subjects with high UCA
levels produce more TT-T lesions and has slower repair of the
those lesions. In contrast, the amount of repaired TT-C
photoproducts after 24 h showed positive correlation to baseline
cis-UCA levels. The immediate post-UV levels of TT=T CPD had
a negative correlation with cis-UCA produced through photo-
isomerization. Because the number of subjects in the analyzes was
only 15±17, however, we have to interpret the data very carefully.
The required sample size would be 30 for detecting the correlation
coef®cient > 0.5 for signi®cance level 0.05 and study power of
80%. A notable general feature might be the tendency of the
parameters to have positive correlation coef®cients except in the
case of TT=T lesions (Table II). The TT=C photoproducts
showed no correlation to UCA. Poor correlation was also seen
between the amount of repaired photoproducts and produced
UCA (Table II, column on the right). There were no signi®cant
differences in the repair kinetics of the photoproduct types,
produced total UCA, or UCA photoisomerization between the
CMM, BCC, and control groups (data not shown).
IJland et al studied photobinding of UCA to DNA (IJland et al,
1998), but possible correlation between the photoreactions of the
two major epidermal chromophores, the production of UCA
isomers and the formation or repair of DNA photoproducts, has
not, to our knowledge, been earlier investigated. The results of our
study suggest that some DNA photoproduct processes induced by
solar-simulating UV irradiation of the human skin may be linked to
epidermal UCA. The marked interindividual variation requires the
results to be con®rmed in a larger study.
The authors thank Dr. Tero Vahlberg at the University of Turku for
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Similar Serum Levels of Soluble Forms of Fas and Fas Ligand
in Cutaneous T Cell Lymphoma and Benign Lymphocyte-
Mediated Dermatoses: Relevancy for Defective Apoptosis
Hypothesis
To the Editor:
Cutaneous T cell lymphomas (CTCL) and especially mycosis
fungoides (MF) and its leukemic counterpart SeÂzary syndrome are
the most frequent primitive lymphomas affecting the skin but their
pathomechanisms remain poorly understood to date (Wood, 1995;
Wood et al, 1997). An attractive hypothesis may consider a chronic
and progressive accumulation of CD4+ lymphocytes in skin rather
than a proliferative disease as a fundamental mechanism in MF, at
least during the early stages. A possible mechanism to explain this
putative accumulation of lymphocytes might be an impairment of
the postactivation apoptosis of a population of CD4+ lymphocytes
bearing membrane molecules that target them to the skin (Picker
et al, 1999). In an earlier series of patients we demonstrated that the
expression of Fas/CD95, one of the major molecules involved in
antigen stimulation-induced apoptosis of T lymphocytes (Lynch et al,
1995; Nagata, 1997; Orteu et al, 1998), was signi®cantly decreased
on CD4+ peripheral lymphocytes in CTCL patients when compared
with benign cutaneous disorders involving lymphocytes, such as
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